Gerard Blobe

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

DCI surgeon scientist Tammara Lynn Watts, MD, PhD, role is strategic oversight of EDI across DCI’s clinical and academic workforce.

Here are some of the Duke Cancer Institute faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

Duke Cancer Institute hosted its Sixth Annual Scientific Retreat on Friday, October 25; attracting 166 DCI physicians, researchers, staff, and guests.